NCT07030959View on ClinicalTrials.gov

Study of AUBE00 in Patients With Solid Tumors

PHASE1RecruitingINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

June 5, 2025

Primary Completion Date

June 30, 2030

Study Completion Date

June 30, 2030

Conditions
Solid Tumors
Interventions
DRUG

AUBE00

AUBE00 as an oral administration

Trial Locations (4)

49546

RECRUITING

South Texas Accelerated Research Therapeutics (START) Midwest, Grand Rapids

77030

RECRUITING

The University of Texas MD Anderson Cancer Center, Houston

277-8577

RECRUITING

National Cancer Center Hospital East, Kashiwa

104-0045

RECRUITING

National Cancer Center Hospital, Chuo-ku

Sponsors
All Listed Sponsors
lead

Chugai Pharmaceutical

INDUSTRY

NCT07030959 - Study of AUBE00 in Patients With Solid Tumors | Biotech Hunter | Biotech Hunter